HUNTSMAN CORP (HUN)

US4470111075 - Common Stock

23.97  +0.3 (+1.27%)

Fundamental Rating

3

HUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. HUN has a bad profitability rating. Also its financial health evaluation is rather negative. HUN is quite expensive at the moment. It does show a decent growth rate. Finally HUN also has an excellent dividend rating.



3

1. Profitability

1.1 Basic Checks

In the past year HUN was profitable.
HUN had a positive operating cash flow in the past year.
Each year in the past 5 years HUN has been profitable.
HUN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of 1.39%, HUN perfoms like the industry average, outperforming 42.35% of the companies in the same industry.
The Return On Equity of HUN (3.13%) is comparable to the rest of the industry.
HUN has a Return On Invested Capital of 1.33%. This is in the lower half of the industry: HUN underperforms 69.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HUN is in line with the industry average of 7.47%.
The last Return On Invested Capital (1.33%) for HUN is well below the 3 year average (6.17%), which needs to be investigated, but indicates that HUN had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.39%
ROE 3.13%
ROIC 1.33%
ROA(3y)6.04%
ROA(5y)7.35%
ROE(3y)13.28%
ROE(5y)18.1%
ROIC(3y)6.17%
ROIC(5y)5.32%

1.3 Margins

With a Profit Margin value of 1.65%, HUN is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of HUN has declined.
HUN has a Operating Margin of 1.67%. This is in the lower half of the industry: HUN underperforms 69.41% of its industry peers.
HUN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 14.83%, HUN is not doing good in the industry: 72.94% of the companies in the same industry are doing better.
HUN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.67%
PM (TTM) 1.65%
GM 14.83%
OM growth 3Y-24.67%
OM growth 5Y-31.18%
PM growth 3Y-54.18%
PM growth 5Y-17.9%
GM growth 3Y-6.74%
GM growth 5Y-8.57%

3

2. Health

2.1 Basic Checks

HUN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HUN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HUN has less shares outstanding
The debt/assets ratio for HUN is higher compared to a year ago.

2.2 Solvency

HUN has an Altman-Z score of 2.20. This is not the best score and indicates that HUN is in the grey zone with still only limited risk for bankruptcy at the moment.
HUN's Altman-Z score of 2.20 is in line compared to the rest of the industry. HUN outperforms 57.65% of its industry peers.
HUN has a Debt/Equity ratio of 0.52. This is a neutral value indicating HUN is somewhat dependend on debt financing.
The Debt to Equity ratio of HUN (0.52) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 2.2
ROIC/WACC0.17
WACC7.64%

2.3 Liquidity

A Current Ratio of 1.97 indicates that HUN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.97, HUN perfoms like the industry average, outperforming 44.71% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that HUN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.23, HUN perfoms like the industry average, outperforming 43.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.23

4

3. Growth

3.1 Past

HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.82%.
Measured over the past years, HUN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -35.91% on average per year.
HUN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.83%.
Measured over the past years, HUN shows a decrease in Revenue. The Revenue has been decreasing by -4.28% on average per year.
EPS 1Y (TTM)-88.82%
EPS 3Y-28.38%
EPS 5Y-35.91%
EPS growth Q2Q-625%
Revenue 1Y (TTM)-23.83%
Revenue growth 3Y0.51%
Revenue growth 5Y-4.28%
Revenue growth Q2Q-14.97%

3.2 Future

HUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 79.43% yearly.
Based on estimates for the next years, HUN will show a quite strong growth in Revenue. The Revenue will grow by 8.52% on average per year.
EPS Next Y59.85%
EPS Next 2Y114.32%
EPS Next 3Y79.43%
EPS Next 5YN/A
Revenue Next Year3.39%
Revenue Next 2Y5.52%
Revenue Next 3Y5.22%
Revenue Next 5Y8.52%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 66.58, which means the current valuation is very expensive for HUN.
65.88% of the companies in the same industry are cheaper than HUN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.20, HUN is valued quite expensively.
With a Price/Forward Earnings ratio of 41.65, HUN can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HUN indicates a slightly more expensive valuation: HUN is more expensive than 68.24% of the companies listed in the same industry.
HUN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.63.
Industry RankSector Rank
PE 66.58
Fwd PE 41.65

4.2 Price Multiples

HUN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.8

4.3 Compensation for Growth

HUN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as HUN's earnings are expected to grow with 79.43% in the coming years.
PEG (NY)1.11
PEG (5Y)N/A
EPS Next 2Y114.32%
EPS Next 3Y79.43%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.22%, HUN is a good candidate for dividend investing.
HUN's Dividend Yield is rather good when compared to the industry average which is at 3.34. HUN pays more dividend than 88.24% of the companies in the same industry.
HUN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 4.22%

5.2 History

The dividend of HUN is nicely growing with an annual growth rate of 7.58%!
HUN has paid a dividend for at least 10 years, which is a reliable track record.
HUN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)7.58%
Div Incr Years3
Div Non Decr Years16

5.3 Sustainability

167.33% of the earnings are spent on dividend by HUN. This is not a sustainable payout ratio.
HUN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP167.33%
EPS Next 2Y114.32%
EPS Next 3Y79.43%

HUNTSMAN CORP

NYSE:HUN (4/26/2024, 11:55:03 AM)

23.97

+0.3 (+1.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.15B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 4.22%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 66.58
Fwd PE 41.65
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 3.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.67%
PM (TTM) 1.65%
GM 14.83%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.97
Quick Ratio 1.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-88.82%
EPS 3Y-28.38%
EPS 5Y
EPS growth Q2Q
EPS Next Y59.85%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.83%
Revenue growth 3Y0.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y